These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 10641014
21. Effects of cisplatin on erythropoietin production in rats. Unami A, Nishina N, Terai T, Sato S, Tamura T, Noda K, Mine Y. J Toxicol Sci; 1996 Aug; 21(3):157-65. PubMed ID: 8887884 [Abstract] [Full Text] [Related]
22. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pollak A, Hayde M, Hayn M, Herkner K, Lombard KA, Lubec G, Weninger M, Widness JA. Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438 [Abstract] [Full Text] [Related]
27. Priming dose of phenylhydrazine protects against hemolytic and lethal effects of 2-butoxyethanol. Palkar PS, Philip BK, Reddy RN, Mehendale HM. Toxicol Appl Pharmacol; 2007 Nov 15; 225(1):102-12. PubMed ID: 17850838 [Abstract] [Full Text] [Related]
28. Pharmacodynamic analysis of time-variant cellular disposition: reticulocyte disposition changes in phlebotomized sheep. Freise KJ, Widness JA, Schmidt RL, Veng-Pedersen P. J Pharmacokinet Pharmacodyn; 2007 Aug 15; 34(4):519-47. PubMed ID: 17516153 [Abstract] [Full Text] [Related]
29. The influence of single or repeated phlebotomy on the physiological condition of normal and diseased rats. Furuhama K, Kato M, Suzuki N, Igarashi K, Onodera T. J Toxicol Sci; 1987 Feb 15; 12(1):1-9. PubMed ID: 3599101 [Abstract] [Full Text] [Related]
30. Alterations in bone and erythropoiesis in hemolytic anemia: comparative study in bled, phenylhydrazine-treated and Plasmodium-infected mice. Moreau R, Tshikudi Malu D, Dumais M, Dalko E, Gaudreault V, Roméro H, Martineau C, Kevorkova O, Dardon JS, Dodd EL, Bohle DS, Scorza T. PLoS One; 2012 Feb 15; 7(9):e46101. PubMed ID: 23029401 [Abstract] [Full Text] [Related]
31. [Hematologic changes in rats treated with high doses of vitamin K3 (menadione)]. Alarcón OM, Vásquez F, Acosta A, Burguera JL, Burguera M, Ortega SY. Arch Latinoam Nutr; 1991 Sep 15; 41(3):363-74. PubMed ID: 1824515 [Abstract] [Full Text] [Related]
32. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs. Randolph JF, Stokol T, Scarlett JM, MacLeod JN. Am J Vet Res; 1999 May 15; 60(5):636-42. PubMed ID: 10328437 [Abstract] [Full Text] [Related]
33. An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia. Veng-Pedersen P, Chapel S, Schmidt RL, Al-Huniti NH, Cook RT, Widness JA. Pharm Res; 2002 Nov 15; 19(11):1630-5. PubMed ID: 12458668 [Abstract] [Full Text] [Related]
34. Hemostatic alterations associated with phenylhydrazine-induced anemia in the rat. Naughton BA, Moore E, Bush ME, Lapin DM, Dornfest BS. J Med; 1989 Nov 15; 20(5-6):305-30. PubMed ID: 2628515 [Abstract] [Full Text] [Related]
35. Relationship between absolute and relative hematocrit changes and bone marrow response in rats. Kalaidjieva V, Iliev Z. Folia Med (Plovdiv); 1999 Nov 15; 41(3):56-61. PubMed ID: 10658368 [Abstract] [Full Text] [Related]
36. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Weiner CP, Widness JA. Am J Obstet Gynecol; 1996 Feb 15; 174(2):547-51. PubMed ID: 8623782 [Abstract] [Full Text] [Related]